Northern Trust Corp Anika Therapeutics, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 123,310 shares of ANIK stock, worth $2.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

123,310

Previous 129,937 5.1%

Holding current value

$2.1 Million

Previous $3.29 Million 7.47%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$24.25 - $28.75 $160,704 - $190,526	-6,627 Reduced 5.1%	123,310 $3.05 Million
Q2 2024 Aug 14, 2024	SELL	$24.57 - $28.47 $116,805 - $135,346	-4,754 Reduced 3.53%	129,937 $3.29 Million
Q1 2024 May 14, 2024	SELL	$21.95 - $26.42 $59,901 - $72,100	-2,729 Reduced 1.99%	134,691 $3.42 Million
Q4 2023 Feb 13, 2024	SELL	$18.47 - $23.3 $166,913 - $210,562	-9,037 Reduced 6.17%	137,420 $3.11 Million
Q3 2023 Nov 13, 2023	SELL	$16.98 - $26.1 $223,354 - $343,319	-13,154 Reduced 8.24%	146,457 $2.73 Million
Q2 2023 Aug 11, 2023	SELL	$25.16 - $28.86 $12,152 - $13,939	-483 Reduced 0.3%	159,611 $4.15 Million
Q1 2023 May 15, 2023	BUY	$25.91 - $32.1 $4,326 - $5,360	167 Added 0.1%	160,094 $4.6 Million
Q4 2022 Feb 13, 2023	SELL	$23.85 - $31.91 $175,965 - $235,431	-7,378 Reduced 4.41%	159,927 $4.73 Million
Q3 2022 Nov 14, 2022	SELL	$21.74 - $24.68 $111,178 - $126,213	-5,114 Reduced 2.97%	167,305 $3.98 Million
Q2 2022 Aug 12, 2022	SELL	$20.4 - $25.53 $244,024 - $305,389	-11,962 Reduced 6.49%	172,419 $3.85 Million
Q1 2022 May 13, 2022	SELL	$24.7 - $36.54 $598,900 - $885,985	-24,247 Reduced 11.62%	184,381 $4.63 Million
Q4 2021 Feb 08, 2022	SELL	$35.83 - $45.03 $334,437 - $420,310	-9,334 Reduced 4.28%	208,628 $7.48 Million
Q3 2021 Nov 15, 2021	SELL	$38.75 - $44.47 $48,050 - $55,142	-1,240 Reduced 0.57%	217,962 $9.28 Million
Q2 2021 Aug 13, 2021	BUY	$39.42 - $48.08 $1.03 Million - $1.26 Million	26,118 Added 13.53%	219,202 $9.49 Million
Q1 2021 May 12, 2021	SELL	$32.49 - $45.96 $1.19 Million - $1.69 Million	-36,675 Reduced 15.96%	193,084 $7.88 Million
Q4 2020 Feb 11, 2021	SELL	$32.59 - $45.26 $310,256 - $430,875	-9,520 Reduced 3.98%	229,759 $10.4 Million
Q3 2020 Nov 16, 2020	SELL	$32.56 - $38.57 $246,088 - $291,512	-7,558 Reduced 3.06%	239,279 $8.47 Million
Q2 2020 Aug 14, 2020	BUY	$27.83 - $37.73 $1.55 Million - $2.1 Million	55,540 Added 29.03%	246,837 $9.31 Million
Q1 2020 May 14, 2020	SELL	$22.38 - $54.06 $16,941 - $40,923	-757 Reduced 0.39%	191,297 $5.53 Million
Q4 2019 Feb 14, 2020	SELL	$51.85 - $73.36 $205,066 - $290,138	-3,955 Reduced 2.02%	192,054 $9.96 Million
Q3 2019 Nov 13, 2019	SELL	$40.05 - $57.47 $33,321 - $47,815	-832 Reduced 0.42%	196,009 $10.8 Million
Q2 2019 Aug 13, 2019	BUY	$30.3 - $41.14 $107,322 - $145,717	3,542 Added 1.83%	196,841 $8 Million
Q1 2019 May 13, 2019	SELL	$29.37 - $40.49 $9,016 - $12,430	-307 Reduced 0.16%	193,299 $5.85 Million
Q4 2018 Feb 12, 2019	SELL	$30.16 - $43.0 $126,672 - $180,600	-4,200 Reduced 2.12%	193,606 $6.51 Million
Q3 2018 Nov 14, 2018	BUY	$32.83 - $42.51 $15,068 - $19,512	459 Added 0.23%	197,806 $8.34 Million
Q2 2018 Sep 18, 2018	SELL	$28.77 - $48.27 $27,072 - $45,422	-941 Reduced 0.47%	197,347 $6.32 Million
Q2 2018 Aug 14, 2018	SELL	$28.77 - $48.27 $32,625 - $54,738	-1,134 Reduced 0.57%	198,288 $6.35 Million
Q1 2018 May 09, 2018	BUY	$49.22 - $68.43 $442 - $615	9 Added 0.0%	199,422 $9.92 Million
Q4 2017 Feb 14, 2018	BUY	$52.14 - $59.94 $22,211 - $25,534	426 Added 0.21%	199,413 $10.8 Million
Q3 2017 Nov 13, 2017	BUY	$51.16 - $58.21 $10.2 Million - $11.6 Million	198,987	198,987 $11.5 Million

Others Institutions Holding ANIK

# of Institutions

123

Shares Held

11.4M

Call Options Held

200

Put Options Held

100

View Full List

About Anika Therapeutics, Inc.

Ticker ANIK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,599,900
Market Cap $248M
Description
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...

More about ANIK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Anika Therapeutics, Inc. Transaction History